
Journal Menu
► ▼ Journal Menu-
- Antibiotics Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
22 March 2022
Antibiotics | Recruiting Editorial Board Members for Newly Established Sections
The Sections “Antibiotics in Animal Health”, “Antibiotic Therapy in Infectious Diseases”, “Antimicrobial Materials and Surfaces” and “Antibiofilm Strategies” were launched recently to provide a platform for related articles and improve our competitiveness. Now we are recruiting Editorial Board Members for these new Sections, and we look forward to your applications.
The main responsibilities of the Section Editorial Board Members are as follows:
- Supervising the quality of papers in the Section (when we have new submissions to the Section);
- Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
- Providing any conference/society cooperation recommendations.
This position is open to experts on antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).
Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science.
21 March 2022
Welcoming the New Associate Editor and New Section Editors-in-Chief for Antibiotics
We are pleased to announce that Dr. Krisztina M. Papp-Wallace from the Louis Stokes Cleveland VA Medical Center has been appointed Associate Editor for the journal Antibiotics (ISSN 2079-6382).
We are also pleased to announce the appointment of new Section Editors-in-Chief for recently established Sections. Dr. Serena Riela from the University of Palermo Viale delle Scienze will serve as the section Editor-in-Chief for “Antimicrobial Materials and Surfaces”; Prof. Dr. Max Maurin from the Centre Hospitalier Universitaire Grenoble Alpes will serve in this role for “Antibiotics in Animal Health”; Dr. Wolf-Rainer Abraham from the Helmholtz Centre for Infection Research will fill this position for “Antibiofilm Strategies”; and Dr. Mehran Monchi from the Centre Hospitalier de Melun will serve in this role for “Antibiotic Therapy in Infectious Diseases”.
We are confident that with the guidance of our new Associate Editor and Section Editors-in-Chief, we will continue to improve the reputation and quality of Antibiotics.
16 December 2021
Antibiotics | 10th Anniversary Special Issue Series
The year 2021 marks the 10th anniversary of Antibiotics (ISSN: 2079-6382), a peer-reviewed open access journal on antibiotics. Antibiotics has published more than 1500 papers by more than 8500 authors. We value the contributions made by authors and reviewers. To celebrate this 10th anniversary, we launched a series of themed Special Issues. We warmly welcome you to read these Special Issues. All articles can be accessed online for free. You are also welcome to share this message further with your peers. Please find the information regarding these Special Issues below.
Anniversary Special Issues
“10th Anniversary of Antibiotics—Feature Papers” (Edited by Prof. Dr. Nicholas Dixon)
“10th Anniversary of Antibiotics—New Resources and Strategies in the Search for Antimicrobials” (Edited by Prof. Dr. Jesus Simal-Gandara, Prof. Dr. Lillian Barros and Prof. Dr. Miguel A. Prieto Lage)
“10th Anniversary of Antibiotics - Recent Advances in Antibiotic Biosynthesis” (Edited by Prof. Dr. Manuel Simões)
“10th Anniversary of Antibiotics — Recent Advances in Rational Antimicrobial Use” (Edited by Dr. Albert Figueras)
“10th Anniversary of Antibiotics—Recent Advances in Bacteriophage Therapy” (Edited by Prof. Dr. Adelaide Almeida)
“10th Anniversary of Antibiotics—Recent Advances in Plant-Derived Antibiotics” (Edited by Prof. Dr. William N. Setzer and Dr. Noura Dosoky)
“10th Anniversary of Antibiotics—Recent Advances in Pharmacodynamics of Antibiotics” (Edited by Prof. Dr. Federico Pea)
“10th Anniversary of Antibiotics—Recent Advances in Antibiotic and Antibiotic Resistance Research in Food” (Edited by Prof. Dr. David Rodríguez-Lázaro and Dr. María Ugarte Ruiz)
“10th Anniversary of Antibiotics - Recent Advances in Novel Antimicrobial Agents” (Edited by Prof. Dr. Carlos M. Franco)
“10th Anniversary of Antibiotics–Recent Advances in Antimicrobial Peptides” (Edited by Dr. Jean-Marc Sabatier and Prof. Dr. Zhijian Cao)
22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction
It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
Abate, Antonio Abatzoglou, John T. Abbaszadeh, Mostafa Acharya, U. Rajendra Acharya, Viral V. Agarwal, Ravi P. Ahn, Myung-Ju Airoldi, Laura Ali, Imran Allakhverdiev, Suleyman I. Aluko, Rotimi E. Anasori, Babak Andersson, Dan I. Andes, David Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Arqub, Omar Abu Aschner, Michael Assaraf, Yehuda G. Astruc, Didier Atala, Anthony Atanasov, Atanas G. Atangana, Abdon Bahram, Mohammad Bakris, George L. Balandin, Alexander A. Baleanu, Dumitru Balsamo, Gianpaolo Bando, Yoshio Banks, William A. Bansal-Travers, Maansi Barba, Francisco J. Barros, Lillian Basit, Abdul W. Baskonus, Haci Mehmet Bassetti, Matteo Battino, Maurizio Bell, Jordana T. Bellomo, Nicola Benediktsson, Jon Atli Benelli, Giovanni Benjakul, Soottawat Bhatnagar, Amit Biddle, Stuart J. H. Biondi, Antonio Biondi-Zoccai, Giuseppe Bjarnsholt, Thomas Blaabjerg, Frede Blaschke, Thomas Blay, Jean-Yves Blumwald, Eduardo Blunt, John W. Boffetta, Paolo Bogers, Marcel Bonomo, Robert A. Bowman, David M.J.S. Boyer, Cyrille Brestic, Marian Brevik, Eric C. Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cai, Xingjuan Cai, Jianchao Calhoun, Vince D. Calin, George Cao, Jinde Cao, Guozhong Carvalho, Andre F. Castellanos-Gomez, Andres Cerqueira, Miguel Ângelo Parente Ribeiro Chang, Jo-Shu Chang, Chih-Hao Chastin, Sebastien Chau, Kwok-wing Chemat, Farid Chen, Xiaobo Chen, YangQuan Chen, Jianmin Chen, Chaoji Chen, Min Chen, Qi Chen, Jun Chen, Xi Chen, Peng Chen, Yulin Chen, Bo Chen, Chen Chen, Zhi-Gang Chen, Wei-Hsin Chen, Gang Chen, Yongsheng Chen, Xiang Chen, Yimin Chen, Runsheng Chen, Lidong Chen, Shaowei Chen, Qian Chen, Yu Chen, Shuangming Chiclana, Francisco Cho, Sun Young Choi, Wonyong Chowdhary, Anuradha Choyke, Peter L. Cichocki, Andrzej Corella, Dolores Corma, Avelino Cortes, Javier Cortes, Jorge Costanza, Robert Crommie, Michael F. Cui, Yi Cui, Haiying Cui, Qinghua Cummings, Kenneth Michael Dai, Shifeng Dai, Sheng Daiber, Andreas Davis, Steven J. Dawson, Ted M. de la Fuente-Nunez, Cesar Decker, Eric Andrew Dekel, Avishai Demaria, Marco Deng, Yong Deng, Xiangzheng DePinho, Ronald A. Desneux, Nicolas Dimopoulos, Meletios-Athanasios Ding, Aijun Dionysiou, Dionysios D. Dokmeci, Mehmet Remzi Dolgui, Alexandre Dong, Fan Dou, Shi Xue Dou, Letian Du, Qian Du, Bo Dube, Shanta Rishi Dufresne, Alain Dummer, Reinhard Dupont, Didier Edwards, David Elaissari, Abdelhamid Elhoseny, Mohamed Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estévez, Mario Fabbro, Doriano Facchetti, Antonio Fan, Zhanxi Fang, Chuanglin Fasano, Alessio Fečkan, Michal Felser, Claudia Feng, Liangzhu Fensholt, Rasmus Ferdinandy, Péter Fernandez-Lafuente, Roberto Ferreira, Isabel C. F. R. Filippi, Massimo Fisher, Helen Fortino, Giancarlo Fosso Wamba, Samuel Franceschi, Claudio Fujita, Hamido Fujita, Masayuki Gai, Francesco Gaisford, Simon Galanakis, Charis M. Galluzzi, Lorenzo Galvano, Fabio Gan, Ren-You Gan, Lihua Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Minrui Gao, Huijun Gao, Wei Gao, Huile Garbe, Claus Garcia, Hermenegildo Gasbarrini, Antonio Gasco, Laura Gautret, Philippe Geng, Yong Gerdts, Gunnar Geschwind, Daniel H. Ghadimi, Noradin Ghaffari, Roozbeh Ghamisi, Pedram Giampieri, Francesca Glick, Bernard R. Gnant, Michael Goel, Ajay Gogotsi, Yury Goldewijk, Kees Klein Gong, Jinlong Gong, Yongji Govindan, Kannan Granato, Daniel Grancini, Giulia Green, Douglas R. Grosso, Giuseppe Gu, Ke Guan, Cao Guastella, Adam J. Guerrero, Josep M. Gui, Guan Guizani, Mohsen Guo, Zaiping Gupta, Rangan Gutzmer, Ralf Haase, Dagmar Habibi-Yangjeh, Aziz Hagemann, Stefan Hagger, Martin Hamblin, Michael R. Hammoudeh, Shawkat Han, Heesup Hanes, Justin Harrison, Roy M. Hartung, Hans-Peter Hasanuzzaman, Mirza He, Jr-Hau He, Hongwen He, Jiaqing He, Debiao Henseler, Jörg Herrera, Francisco Herrera-Viedma, Enrique Hetz, Claudio Ho Kim, Jung Holmes, Elaine Hossain, Ekram Hsueh, Po-Ren Hu, Xiaosong Hu, Wenbin Huang, Jianping Huang, Hongwei Huang, Yu Huang, Jianying Huang, Peng Huang, Baibiao Huang, Shaoming Hubacek, Klaus |
Iqbal, Hafiz M. N. |
Saad, Fred |
The full list of 2021 Highly Cited Researchers can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.
--- Highly Cited Researchers (HCR) is a Clarivate product.
16 November 2021
Topical Advisory Panel Established to Support Editorial Board
Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.
The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.
Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.
To qualify as a Topical Advisory Panel Member, applicants must:
- Have expertise and experience in the field related to the journal;
- Have received a Ph.D. in the last 10 years, approximately;
- Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
- Currently hold an independent research position in academia or a government institute.
If you are interested in this role, please contact the editorial office by email.
We look forward to hearing from you soon.
25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October
Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.
The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.
For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.
International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.
Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.
Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.
The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.
Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.
We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.
- 25 October 2021
Energies journal and Institute of Mechanics, Chinese Academy of Sciences
- 28 October 2021
Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
- 29 October 2021
Processes journal and Beijing Institute of Technology
- 29 October 2021
Coatings journal and Wuhan University of Technology
MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.
27 September 2021
Recruiting Section Editors-in-Chief for New Sections of Antibiotics

According to the aim and scope of the journal and the papers we are publishing, we are launching four new sections to improve our competitiveness and the strength of our editorial team. These sections are “Antibiotics in Animal Health”, “Antibiotic Therapy in Infectious Diseases”, “Antimicrobial Materials and Surfaces”, and “Antibiofilm Strategies”. We are recruiting Section Editors-in-Chief for these four sections of Antibiotics.
The main responsibilities of the Section Editors-in-Chief are as follows:
- Supervising the quality of the papers in their section (when we have new submissions to the section);
- Acting as, or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
- Providing any conference/society cooperation recommendations.
This position is open to experts on related aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).
Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open-access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category, and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science.
23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:
- Adriana Burlea-Schiopoiu;
- Alban Kuriqi;
- Álvaro González-Vila;
- Alessandro Alaimo;
- Alexey Beskopylny;
- Alexander Yu Churyumov;
- Alberto Fernández-Isabel;
- Andrea Mastinu;
- Antonios N. Papadopoulos;
- Anton Rassõlkin;
- Antonio Humberto Hamad Minervino;
- Arkadiusz Matwijczuk;
- Artur Słomka;
- Baojie He;
- Bartłomiej Potaniec;
- Bojan Đurin;
- Camilo Arturo Rodriguez Diaz;
- Carmelo Maria Musarella;
- Chiachung Chen;
- Chiman Kwan;
- Cristian Busu;
- Danil Pimenov;
- Dan-Cristian Dabija;
- Delfín Ortega-Sánchez;
- Demetrio Antonio Zema;
- Denis Butusov;
- Elena Lucchi;
- Gaurab Dutta;
- Livia Anastasiu;
- M. R. Safaei.
For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.
22 September 2021
MDPI Joins SDG Publishers Compact
UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.
MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.
Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.
The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.
For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com
18 September 2021
Meet Us at the 2021 Chinese Medicinal Chemistry Symposium and CPA-EFMC International Symposium on Medicinal Chemistry (CMCS 2021) in Shenyang, China, 27–30 September 2021

MDPI will be attending the 2021 Chinese Medicinal Chemistry Symposium and CPA-EFMC International Symposium on Medicinal Chemistry (CMCS 2021), hosted by the Division of Medicinal Chemistry and Chinese Pharmaceutical Association, which will be held from Monday, 27 September, until Thursday, 30 September 2021, in Shenyang, China.
As a top-level biennial event in the medicinal chemistry and the related fields in China, CMCS aims to boost the information exchange and communication between peers in frontiers of medicinal chemistry and the relevant fields. According to the cooperation framework agreement signed by the Chinese Pharmaceutical Association (CPA) and the European Federation for Medicinal Chemistry (EFMC), the CPA-EFMC International Symposium on Medicinal Chemistry (CPA-EFMC ISMC) will be held concurrently.
The topics covered will include the frontiers and hotspots of medicinal chemistry and chemical biology, innovative drug research for major diseases, rational drug design strategies and new methods, lead compound discovery and optimization strategies, natural active substance discovery and structural modification, and modern drug preparation technology and innovation craft.
The following MDPI journals will be represented:
If you are also attending this conference, please feel free to stop by our booth (#16). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://cmcs2021.syphu.edu.cn/Home.htm.